Newhall Charles W Iii - Net Worth and Insider Trading

Newhall Charles W Iii Net Worth

The estimated net worth of Newhall Charles W Iii is at least $978 Million dollars as of 2024-11-29. Newhall Charles W Iii is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 24,538,379 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $783 Million. Newhall Charles W Iii is the 10% Owner of Echo Global Logistics Inc and owns about 2,420,219 shares of Echo Global Logistics Inc (ECHO) stock worth over $117 Million. Newhall Charles W Iii is also the 10% Owner of Amicus Therapeutics Inc and owns about 5,650,340 shares of Amicus Therapeutics Inc (FOLD) stock worth over $56 Million. Besides these, Newhall Charles W Iii also holds InnerWorkings Inc (INWK) , Supernus Pharmaceuticals Inc (SUPN) , Catalyst Biosciences Inc (CBIO) , Novation Companies Inc (NOVCQ) . Details can be seen in Newhall Charles W Iii's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Newhall Charles W Iii has not made any transactions after 2024-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Newhall Charles W Iii

Newhall Charles W Iii Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Newhall Charles W Iii owns 21 companies in total, including Supernus Pharmaceuticals Inc (SUPN) , Vitae Pharmaceuticals Inc (VTAE) , and Workday Inc (WDAY) among others .

Click here to see the complete history of Newhall Charles W Iii’s form 4 insider trades.

Insider Ownership Summary of Newhall Charles W Iii

Ticker	Comapny	Transaction Date	Type of Owner
SUPN	Supernus Pharmaceuticals Inc	2024-11-11	director
VTAE	Vitae Pharmaceuticals Inc	2015-07-01	director
WDAY	Workday Inc	2012-10-11	10 percent owner
		2012-07-02	director & 10 percent owner
		2012-03-28	10 percent owner
		2012-03-07	10 percent owner
		2009-10-01	10 percent owner
		2011-11-03	10 percent owner
		2011-08-08	10 percent owner
		2011-05-03	10 percent owner
		2006-05-23	10 percent owner
		2011-03-10	10 percent owner
		2010-08-30	10 percent owner
		2010-06-30	10 percent owner
		2010-06-23	10 percent owner
		2009-02-20	10 percent owner
		2006-05-09	10 percent owner
		2007-08-14	10 percent owner
		2006-04-12	10 percent owner
		2004-02-20	10 percent owner
		2009-04-03	10 percent owner

Newhall Charles W Iii Latest Holdings Summary

Newhall Charles W Iii currently owns a total of 7 stocks. Among these stocks, Newhall Charles W Iii owns 24,538,379 shares of iShares Indl/Office Real Estate Capped (FNIO) as of November 28, 2011, with a value of $783 Million and a weighting of 79.98%. Newhall Charles W Iii owns 2,420,219 shares of Echo Global Logistics Inc (ECHO) as of October 1, 2009, with a value of $117 Million and a weighting of 11.93%. Newhall Charles W Iii also owns 5,650,340 shares of Amicus Therapeutics Inc (FOLD) as of March 7, 2012, with a value of $56 Million and a weighting of 5.75%. The other 4 stocks InnerWorkings Inc (INWK) , Supernus Pharmaceuticals Inc (SUPN) , Catalyst Biosciences Inc (CBIO) , Novation Companies Inc (NOVCQ) have a combined weighting of 2.34% among all his current holdings.

Latest Holdings of Newhall Charles W Iii

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
FNIO	iShares Indl/Office Real Estate Capped	2011-11-28	24,538,379	31.89	782,528,906
ECHO	Echo Global Logistics Inc	2009-10-01	2,420,219	48.24	116,751,365
FOLD	Amicus Therapeutics Inc	2012-03-07	5,650,340	9.96	56,277,386
INWK	InnerWorkings Inc	2012-02-29	6,029,190	2.99	18,027,278
SUPN	Supernus Pharmaceuticals Inc	2024-11-11	130,275	36.99	4,818,872
CBIO	Catalyst Biosciences Inc	2006-04-12	3,343	7.67	25,639
NOVCQ	Novation Companies Inc	2006-05-15	1,225,179	0.00	123

Holding Weightings of Newhall Charles W Iii

Newhall Charles W Iii Form 4 Trading Tracker

According to the SEC Form 4 filings, Newhall Charles W Iii has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 1,291,493 shares on November 28, 2011, which brought Newhall Charles W Iii around $41 Million.

According to the SEC Form 4 filings, Newhall Charles W Iii has made a total of 0 transactions in Echo Global Logistics Inc (ECHO) over the past 5 years. The most-recent trade in Echo Global Logistics Inc is the sale of 0 shares on October 1, 2009, which brought Newhall Charles W Iii around $0.

According to the SEC Form 4 filings, Newhall Charles W Iii has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the acquisition of 1,140,000 shares on March 7, 2012, which cost Newhall Charles W Iii around $6 Million.

More details on Newhall Charles W Iii's insider transactions can be found in the Insider Trading History of Newhall Charles W Iii table.

Insider Trading History of Newhall Charles W Iii

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Newhall Charles W Iii Trading Performance

GuruFocus tracks the stock performance after each of Newhall Charles W Iii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Newhall Charles W Iii is 13.21%. GuruFocus also compares Newhall Charles W Iii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Newhall Charles W Iii within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Newhall Charles W Iii's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Newhall Charles W Iii

Average Return

Average return per transaction

Outperforming Transactions

1 out of 4 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-11.54
Relative Return to S&P 500(%)	-10.04

Newhall Charles W Iii Ownership Network

Ownership Network List of Newhall Charles W Iii

No Data

Ownership Network Relation of Newhall Charles W Iii

Newhall Charles W Iii Owned Company Details

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Newhall Charles W Iii is the director of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include director & President & CEO Jack A. Khattar , Sr VP & Quality & GMP Oper. & IT Frank Mottola , and Sr. VP of IP & CSO Padmanabh P. Bhatt .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Newhall Charles W Iii made 2 insider transaction in Supernus Pharmaceuticals Inc (SUPN) with a net sale of 13,200. Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 98,505 shares made by Padmanabh P. Bhatt , a net sale of 38,886 shares made by Georges Gemayel , and a net sale of 21,235 shares made by Tami Tillotson Martin .

In summary, during the past 3 months, insiders sold 323,308 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 323,308 shares. During the past 18 months, 455,751 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 455,751 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Vitae Pharmaceuticals Inc do?

Who are the key executives at Vitae Pharmaceuticals Inc?

Newhall Charles W Iii is the director of Vitae Pharmaceuticals Inc. Other key executives at Vitae Pharmaceuticals Inc include Chief Financial Officer Richard Steven Morris , General Counsel Scott Applebaum , and Chief Medical Officer Carole Sable .

Vitae Pharmaceuticals Inc (VTAE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vitae Pharmaceuticals Inc (VTAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vitae Pharmaceuticals Inc (VTAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vitae Pharmaceuticals Inc (VTAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vitae Pharmaceuticals Inc Insider Transactions

No Available Data

What does Workday Inc do?

Who are the key executives at Workday Inc?

Newhall Charles W Iii is the 10 percent owner of Workday Inc. Other key executives at Workday Inc include 10 percent owner David A Duffield , EVP & General Counsel & Secty Richard Harry Sauer , and Co-President Sayan Chakraborty .

Workday Inc (WDAY) Insider Trades Summary

Over the past 18 months, Newhall Charles W Iii made no insider transaction in Workday Inc (WDAY). Other recent insider transactions involving Workday Inc (WDAY) include a net sale of 2,282,002 shares made by David A Duffield , a net sale of 30,871 shares made by Douglas A. Robinson , and a net sale of 57,562 shares made by Richard Harry Sauer .

In summary, during the past 3 months, insiders sold 575,861 shares of Workday Inc (WDAY) in total and bought 0 shares, with a net sale of 575,861 shares. During the past 18 months, 2,524,211 shares of Workday Inc (WDAY) were sold and 8,676 shares were bought by its insiders, resulting in a net sale of 2,515,535 shares.

Workday Inc (WDAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Workday Inc Insider Transactions

No Available Data

What does W World Corp do?

Who are the key executives at W World Corp?

Newhall Charles W Iii is the director & 10 percent owner of W World Corp. Other key executives at W World Corp include director & 10 percent owner Anthony B Evnin , President and CFO Neill Sydney Colin , and 10 percent owner C Richard Kramlich .

W World Corp (WWHC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of W World Corp (WWHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of W World Corp (WWHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

W World Corp (WWHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

W World Corp Insider Transactions

No Available Data

What does InnerWorkings Inc do?

Who are the key executives at InnerWorkings Inc?

Newhall Charles W Iii is the 10 percent owner of InnerWorkings Inc. Other key executives at InnerWorkings Inc include director & President and CEO Richard S Stoddart , Chief Accounting Officer John Bosshart , and Executive VP and CFO Donald W Pearson .

InnerWorkings Inc (INWK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InnerWorkings Inc (INWK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InnerWorkings Inc (INWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InnerWorkings Inc (INWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

InnerWorkings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Newhall Charles W Iii is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Newhall Charles W Iii made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 232,762 shares made by Bradley L Campbell , a net sale of 327,191 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 30,401 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 30,401 shares. During the past 18 months, 797,737 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 797,737 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

Newhall Charles W Iii is the 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does Groupon Inc do?

Who are the key executives at Groupon Inc?

Newhall Charles W Iii is the 10 percent owner of Groupon Inc. Other key executives at Groupon Inc include other: See Footnote 1 and Remarks Dusan Senkypl , Interim CAO Kyle Netzly , and Chief Financial Officer Jiri Ponrt .

Groupon Inc (GRPN) Insider Trades Summary

Over the past 18 months, Newhall Charles W Iii made no insider transaction in Groupon Inc (GRPN). Other recent insider transactions involving Groupon Inc (GRPN) include a net purchase of 323,344 shares made by Dusan Senkypl , a net purchase of 15,000 shares made by Jason Harinstein , and a net sale of 4,583 shares made by Robert J Bass .

In summary, during the past 3 months, insiders sold 0 shares of Groupon Inc (GRPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,583 shares of Groupon Inc (GRPN) were sold and 338,344 shares were bought by its insiders, resulting in a net purchase of 333,761 shares.

Groupon Inc (GRPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Groupon Inc Insider Transactions

No Available Data

What does Glu Mobile Inc do?

Who are the key executives at Glu Mobile Inc?

Newhall Charles W Iii is the 10 percent owner of Glu Mobile Inc. Other key executives at Glu Mobile Inc include EVP & COO and CFO Eric R Ludwig , Senior Vice President & Revenue Becky Ann Hughes , and SVP & Business & Corp. Dev. Chris Akhavan .

Glu Mobile Inc (GLUU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Glu Mobile Inc (GLUU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Glu Mobile Inc (GLUU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Glu Mobile Inc (GLUU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glu Mobile Inc Insider Transactions

No Available Data

What does Boingo Wireless Inc do?

Who are the key executives at Boingo Wireless Inc?

Newhall Charles W Iii is the 10 percent owner of Boingo Wireless Inc. Other key executives at Boingo Wireless Inc include Chief Technology Officer Derek Peterson , Chief Financial Officer Peter Hovenier , and Chief Marketing Officer Dawn Callahan .

Boingo Wireless Inc (WIFI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Boingo Wireless Inc (WIFI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Boingo Wireless Inc (WIFI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Boingo Wireless Inc (WIFI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Boingo Wireless Inc Insider Transactions

No Available Data

What does Vonage Holdings Corp do?

Who are the key executives at Vonage Holdings Corp?

Newhall Charles W Iii is the 10 percent owner of Vonage Holdings Corp. Other key executives at Vonage Holdings Corp include SVP Corporate Development Vinod Lala , Interim Chief Legal Officer Randy K. Rutherford , and director & Chief Executive Officer Rory P Read .

Vonage Holdings Corp (VG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vonage Holdings Corp (VG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vonage Holdings Corp (VG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vonage Holdings Corp (VG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vonage Holdings Corp Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Newhall Charles W Iii is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Financial Engines Inc do?

Who are the key executives at Financial Engines Inc?

Newhall Charles W Iii is the 10 percent owner of Financial Engines Inc. Other key executives at Financial Engines Inc include EVP & COO & Pres FE Advisors John Bunch , EVP & CFO Craig L Foster , and other: See footnotes (1)(2)(3)(4) Warburg Pincus Llc .

Financial Engines Inc (FNGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Financial Engines Inc (FNGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Financial Engines Inc (FNGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Financial Engines Inc (FNGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Financial Engines Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Newhall Charles W Iii is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Voltari Corp do?

Who are the key executives at Voltari Corp?

Newhall Charles W Iii is the 10 percent owner of Voltari Corp. Other key executives at Voltari Corp include 10 percent owner Carl C Icahn , Chief Financial Officer Nathan Yu-gai Fong , and SVP & Gen Counsel & Corp Sec Richard Jr Leigh .

Voltari Corp (VLTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Voltari Corp (VLTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Voltari Corp (VLTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Voltari Corp (VLTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Voltari Corp Insider Transactions

No Available Data

What does Inteliquent Inc do?

Who are the key executives at Inteliquent Inc?

Newhall Charles W Iii is the 10 percent owner of Inteliquent Inc. Other key executives at Inteliquent Inc include director & President and CEO Matthew Jr Carter , Chief Financial Officer / EVP Kurt Abkemeier , and 10 percent owner C Richard Kramlich .

Inteliquent Inc (IQNT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inteliquent Inc (IQNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inteliquent Inc (IQNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inteliquent Inc (IQNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inteliquent Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Newhall Charles W Iii is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Newhall Charles W Iii made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does DZS Inc do?

Who are the key executives at DZS Inc?

Newhall Charles W Iii is the 10 percent owner of DZS Inc. Other key executives at DZS Inc include Chief Customer Officer & AEMEA Gunter Reiss , Chief Financial Officer Misty Dawn Kawecki , and director & President & CEO Charles D Vogt .

DZS Inc (DZSI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DZS Inc (DZSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DZS Inc (DZSI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DZS Inc (DZSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

DZS Inc Insider Transactions

No Available Data

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Newhall Charles W Iii is the 10 percent owner of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does Aradigm Corp do?

Who are the key executives at Aradigm Corp?

Newhall Charles W Iii is the 10 percent owner of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner 21 April Fund Lp .

Aradigm Corp (ARDMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aradigm Corp Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Newhall Charles W Iii is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Newhall Charles W Iii made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 10,637 shares made by Daniel R. Chevallard , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,637 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 89,363 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

Newhall Charles W Iii Mailing Address

Above is the net worth, insider trading, and ownership report for Newhall Charles W Iii. You might contact Newhall Charles W Iii via mailing address: 1119 St Paul St, Baltimore Md 21202.

Discussions on Newhall Charles W Iii

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.